Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Annexin 2/factor xa-mediated signal transduction.

Pizzo SV.

Circ Res. 2008 Feb 29;102(4):389-91. doi: 10.1161/CIRCRESAHA.108.172080. No abstract available.

2.

Factor Xa binding to annexin 2 mediates signal transduction via protease-activated receptor 1.

Bhattacharjee G, Ahamed J, Pawlinski R, Liu C, Mackman N, Ruf W, Edgington TS.

Circ Res. 2008 Feb 29;102(4):457-64. doi: 10.1161/CIRCRESAHA.107.167759. Epub 2008 Jan 3.

3.

Tyrosine phosphorylation of annexin A2 regulates Rho-mediated actin rearrangement and cell adhesion.

Rescher U, Ludwig C, Konietzko V, Kharitonenkov A, Gerke V.

J Cell Sci. 2008 Jul 1;121(Pt 13):2177-85. doi: 10.1242/jcs.028415.

4.

Factor Xa: at the crossroads between coagulation and signaling in physiology and disease.

Borensztajn K, Peppelenbosch MP, Spek CA.

Trends Mol Med. 2008 Oct;14(10):429-40. doi: 10.1016/j.molmed.2008.08.001. Epub 2008 Sep 4. Review.

PMID:
18774340
5.

"Annexinopathies"--a new class of diseases.

Rand JH.

N Engl J Med. 1999 Apr 1;340(13):1035-6. No abstract available.

PMID:
10099148
6.

Endothelial protein C receptor is required for tissue factor ternary complex signaling in the mouse.

Disse J, Ruf W.

J Thromb Haemost. 2011 Dec;9(12):2516-8. doi: 10.1111/j.1538-7836.2011.04521.x. No abstract available.

7.

Coagulation factor Xa signaling: the link between coagulation and inflammatory bowel disease?

Borensztajn K, Peppelenbosch MP, Spek CA.

Trends Pharmacol Sci. 2009 Jan;30(1):8-16. doi: 10.1016/j.tips.2008.10.007. Epub 2008 Dec 6. Review.

PMID:
19058861
8.

Epstein-Barr virus latent membrane protein 1 mediates serine 25 phosphorylation and nuclear entry of annexin A2 via PI-PLC-PKCalpha/PKCbeta pathway.

Luo W, Yan G, Li L, Wang Z, Liu H, Zhou S, Liu S, Tang M, Yi W, Dong Z, Cao Y.

Mol Carcinog. 2008 Dec;47(12):934-46. doi: 10.1002/mc.20445.

PMID:
18412141
9.

Coagulopathy in APL: a step forward?

Avvisati G.

Blood. 2012 Jul 5;120(1):4-6. doi: 10.1182/blood-2012-05-427427.

10.

Neuroscience. A new molecule to brighten the mood.

Sharp T.

Science. 2006 Jan 6;311(5757):45-6. No abstract available.

PMID:
16400139
11.

Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activation.

Borensztajn K, Bijlsma MF, Reitsma PH, Peppelenbosch MP, Spek CA.

Thromb Res. 2009 Jun;124(2):219-25. doi: 10.1016/j.thromres.2009.01.015. Epub 2009 Feb 27.

PMID:
19250659
12.

Hematopoietic lineage cell-specific protein-1 (HS1) regulates PAR-mediated ERK activation and thromboxane generation in platelets.

Kahner BN, Dorsam RT, Kim S, Shankar H, Kitamura D, Kunapuli SP.

Platelets. 2008 Dec;19(8):614-23. doi: 10.1080/09537100802351057.

PMID:
19012179
13.

Regulation of the low-dose radiation paracrine-specific anchorage-independent growth response by annexin A2.

Weber TJ, Opresko LK, Waisman DM, Newton GJ, Quesenberry RD, Bollinger N, Moore RJ, Smith RD.

Radiat Res. 2009 Jul;172(1):96-105. doi: 10.1667/RR1220.1.

PMID:
19580511
14.

Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth.

Braden AR, Kafka MT, Cunningham L, Jones H, Vishwanatha JK.

J Nanosci Nanotechnol. 2009 May;9(5):2856-65.

PMID:
19452941
15.

Cytoprotective effect of activated protein C: specificity of PAR-1 signaling.

Crawley JT, Efthymiou M.

J Thromb Haemost. 2008 Jun;6(6):951-3. doi: 10.1111/j.1538-7836.2008.02951.x. Epub 2008 Mar 21. No abstract available.

16.

Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells.

Naldini A, Filippi I, Ardinghi C, Silini A, Giavazzi R, Carraro F.

Eur J Cancer. 2009 Feb;45(3):454-60. doi: 10.1016/j.ejca.2008.10.012. Epub 2008 Nov 27.

PMID:
19046876
17.

Increased expression of Annexin A2 in oral squamous cell carcinoma.

Zhong LP, Wei KJ, Yang X, Zhang L, Zhou XJ, Pan HY, Li J, Chen WT, Zhang ZY.

Arch Oral Biol. 2009 Jan;54(1):17-25. doi: 10.1016/j.archoralbio.2008.08.006. Epub 2008 Sep 25.

PMID:
18822406
18.

Annexin A2 is involved in pig (Sus scrofa)sperm-oviduct interaction.

Teijeiro JM, Ignotz GG, Marini PE.

Mol Reprod Dev. 2009 Apr;76(4):334-41. doi: 10.1002/mrd.20958.

PMID:
18932200
19.

The contribution of anti-Xa and anti-IIa activities to the profibrinolytic activity of low-molecular-weight heparins.

Ammollo CT, Semeraro F, Semeraro N, Colucci M.

Thromb Haemost. 2009 Apr;101(4):782-5. No abstract available.

PMID:
19350129
20.

Thrombin induces fibroblast CCL2/JE production and release via coupling of PAR1 to Galphaq and cooperation between ERK1/2 and Rho kinase signaling pathways.

Deng X, Mercer PF, Scotton CJ, Gilchrist A, Chambers RC.

Mol Biol Cell. 2008 Jun;19(6):2520-33. doi: 10.1091/mbc.E07-07-0720. Epub 2008 Mar 19.

Supplemental Content

Support Center